Moolec Science (MLEC) Assets Average (2023 - 2026)
Moolec Science (MLEC) reported Assets Average of $103.8 million for Q1 2026, down 32.59% sequentially from $154.0 million in Q4 2025.
Moolec Science (MLEC) Assets Average (2023 - 2026) Analysis & Trends
Moolec Science (MLEC) has 4 years of Assets Average data on file, last reported at $103.8 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average changed N/A year-over-year to $103.8 million; the trailing twelve-month figure through Mar 2026 stood at $103.8 million (changed N/A YoY), and the FY2025 full-year result was $577.2 million, up 18.53% from the prior year.
- Assets Average slipped to $103.8 million in Q1 2026, from $154.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $491.2 million in Q3 2024 to a low of $15.0 million in Q1 2023.
- A 4-year average of $135.1 million and a median of $32.0 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average jumped 3052.68% in 2024 and sank 75.82% in 2025, its largest moves.
- Tracing MLEC's Assets Average over 4 years: stood at $21.9 million in 2023, then surged by 45.94% to $32.0 million in 2024, then soared by 381.62% to $154.0 million in 2025, then tumbled by 32.59% to $103.8 million in 2026.
- Business Quant data shows MLEC's Assets Average at $103.8 million in Q1 2026, $154.0 million in Q4 2025, and $118.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,913.26 Bn | 1,913.20 Bn | - | 65.01 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 40.89 Mn |
| 4 | BeOne Medicines | 471.02 Bn | 466.23 Bn | 1.35 Bn | 8.37 Bn |
| 5 | Vertex Pharmaceuticals | 122.17 Bn | 114.92 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.10 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 55.60 Bn | 50.42 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.39 Bn | 34.38 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Moolec Science | 5.35 Bn | 5.35 Bn | - | 103.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103.79 Mn |
| Dec 31, 2025 | 153.97 Mn |
| Jun 30, 2025 | 117.97 Mn |
| Dec 31, 2024 | 31.97 Mn |
| Sep 30, 2024 | 491.20 Mn |
| Jun 30, 2024 | 487.89 Mn |
| Mar 31, 2024 | 23.64 Mn |
| Dec 31, 2023 | 21.91 Mn |
| Sep 30, 2023 | 23.27 Mn |
| Jun 30, 2023 | 15.48 Mn |
| Mar 31, 2023 | 15.04 Mn |